PR & News About AIF

Central Florida’s Autism Impact Fund Flush with Cash and Looking for Deals Even as VC Industry Slows

“[AIF] is…the only fund that knows this space so well. They have an influence beyond the checks they write.” — Dr. Neil Hattangadi, MD. CEO & Co-Founder of Cortica.

Published June 28, 2022

Can Virtual Reality Help Autistic Children Navigate the Real World?

One company, Floreo, is hoping their tools will lead the way, despite some criticisms from autism self-advocates

Published June 14, 2022

Exclusive: SpectrumAi Raises $9M Seed for Virtual Autism Care

SpectrumAi, a startup focused on quantifying autism treatment, raised $9 million in a seed round, founder and CEO Ling Shao tells Axios

Published June 1, 2022

Autism Impact Fund Makes Strategic Investment in Cortica

Investment by AIF further validates Cortica’s distinct tech-enabled care model

Published April 20, 2022

Autism Impact Fund Rings Closing Bell at New York Stock Exchange

An extraordinary day for the Autism Impact Fund and an important step in our mission to revolutionize the status quo for diagnosing, treating and living with autism

Published April 19, 2022

AIF Co-Founder Interviewed on CNBC Squawk Box: People with Autism Don’t Need Charity, They Need Opportunities

Chris Male, Autism Impact Fund co-founder and managing partner, joins CNBC’s ‘Squawk Box’ during Autism Awareness Month to discuss how the fund is working to be the investment and innovation arm of the autism community

Published April 18, 2022

New venture fund aims to become the ‘investment and innovation arm of the autism community’

AIF, which has Uber’s CEO as an advisor, has invested in seven early-stage companies

Published November 10, 2021

Autism Impact Fund Makes First Investments in Seven Early-stage Companies

Venture capital fund includes world-class Investment Advisory Board and aims to be the investment and innovation arm of the autism community

Published November 10, 2021

Axial Therapeutics Raises $37.25 Million in Series C Financing to Advance its Pipeline of Gut-Targeted Small Molecule Drugs for Neurological Diseases and Disorders

Proceeds will support Axial’s randomized, controlled Phase 2b clinical trial for lead candidate, AB-2004, a molecular therapeutic to treat irritability in children with autism.

Published October 13, 2021

Yamo Pharmaceuticals Receives Investment from Autism Impact Fund to Support Phase 2 Study of L1-79 in Autism Spectrum Disorder

The Autism Impact Fund has made a capital investment in Yamo to support a Phase 2 study of L1-79 in adolescents and adults with ASD. 

Published November 10, 2021

With New Funding, Auticon Looks to Grow Job Opportunities for Autistic Adults

Technology consulting firm Auticon just received a boost to its mission of helping companies hire more autistic employees.


Published February 16, 2022

Autism Impact Fund leads investment round in auticon, a global technology consulting firm that employs neurodiverse adults

The Autism Impact Fund (AIF), whose mission is to revolutionize the status quo for diagnosing, treating and living with autism through a venture capital model, has led a new investment round in auticon, a technology consulting provider that is the global leader in employing autistic individuals.

Published February 17, 2022